Publication: 4772

Adjuvant Palbociclib for ER+ Breast Cancer in the PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): Post-Recurrence Treatment and Overall Survival
Google Scholar   
Citation:
Meeting Instance:
SABCS 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
AFT
Endpoint:
Primary
Analysis:
Long-Term-Followup
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
AFT, ABCSG, NRG, PrECOG;  
Corr. Author:
 
Authors:
                                                             
Networks:
AL068, CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MD017, LAPS-PA015, METROMIN, VT004   
Study
AFT-05
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: